Viewing nowEdobavel Tablet 0.5 mg (Rasagiline Mesylate)
Rasagiline Mesylate 0.78mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

MFDS item code 201907379 · Approved 2019.10.22 · Insurance code 643308430
Treatment of idiopathic Parkinson's disease
This medication is used for the treatment of idiopathic Parkinson's disease. Initially, it may be used alone or as an adjunct therapy with dopamine agonists. Additionally, it is used as an adjunct treatment with levodopa for patients experiencing 'end of dose fluctuations,' which are motor fluctuations associated with the disease. In other words, it is actively used for the improvement of Parkinson's symptoms and enhancement of motor function.
This medicine is administered orally to adults once daily as monotherapy or adjunctive therapy. 1) Monotherapy or adjunctive therapy with a dopamine agonist: Administer 1mg orally once daily. 2) Adjunctive therapy with levodopa: The recommended initial dose for patients taking levodopa is 0.5mg once daily. If well tolerated and an adequate clinical response is not observed, the dose may be increased to 1mg once daily. This medicine may be taken with or without food.
This medication should not be administered to patients with known allergies to the active ingredient or any other components. Furthermore, it may be dangerous when taken in conjunction with other MAO inhibitors or certain analgesics, cold medications, and antidepressants; therefore, patients who are currently taking or have recently discontinued such medications should avoid using this drug. Patients with moderate to severe liver impairment should not take this medication, and caution is advised for patients with mild liver impairment. This medication can cause various side effects, including headache, dizziness, nausea, insomnia, muscle pain, hallucinations, depression, blood pressure changes, and skin rash. In particular, motor symptoms may worsen in Parkinson's patients, and there is a risk of sudden increases or decreases in blood pressure; hence, caution is essential. During treatment with this medication, impulse control disorders may occur, so patients and caregivers should closely monitor for changes such as compulsive behaviors, pathological gambling, and excessive spending. Drowsiness or sudden sleep symptoms might appear when driving or operating machinery, and patients experiencing such symptoms should avoid hazardous tasks. Women who are pregnant or breastfeeding should exercise caution when using this medication, as safety has not been established, and consulting a healthcare professional is important. Overdose can lead to serious side effects, so it is crucial to adhere to the prescribed dosage. Finally, store this medication out of reach of children and store it at the appropriate temperature, avoiding transferring it to another container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air or moisture accumulation. Moreover, it should be kept at a cool temperature between 1 to 25 degrees Celsius, avoiding extremely hot or cold environments.
Flat, round tablets with a white or almost white color and edged sides
10 tablets/PTP[10 tablets/PTP*1], 30 tablets/PTP[10 tablets/PTP*3], 10 tablets/bottle, 30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRasagiline Mesylate 0.78mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Hana Lundbeck Co., Ltd.

Rasagiline Mesylate 0.78mg
Tablet · Prescription medication
Korea Lundbeck Co., Ltd.

Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Korea Pharma Co., Ltd.

Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Myungin Pharmaceutical Co., Ltd.

Rasagiline Mesylate 0.78mg
Tablet · Prescription medication
Myungin Pharmaceutical Co., Ltd.

Rasagiline Mesylate 0.78mg
Tablet · Prescription medication
Sam-il Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.